Recursion Pharmaceuticals Inc (RXRX)
10.90
+0.37
(+3.51%)
USD |
NASDAQ |
Feb 18, 10:41
Recursion Pharmaceuticals Market Cap: 3.124B for Feb. 18, 2025
View 4,000+ Financial Data Types:
Add
Browse
Market Cap Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
Absci Corp | 701.77M |
Enanta Pharmaceuticals Inc | 152.53M |
Arvinas Inc | 1.395B |
Bioventus Inc | 685.71M |
Moderna Inc | 13.80B |
Market Cap Related Metrics
PS Ratio | 41.46 |
PEG Ratio | -1.141 |
Price to Book Value | 5.956 |
Price | 10.90 |
Earnings Yield | -14.22% |
PEGY Ratio | -1.141 |